Seeing Is Believing
Currently out of the existing stock ratings of Ami Fadia, 229 are a BUY (87.07%), 28 are a HOLD (10.65%), 6 are a SELL (2.28%).
Analyst Ami Fadia works at NEEDHAM with a stock forecast success ratio of 43.66% fulfilled within 176.1 days on average. Previously, Ami Fadia worked at LEERINK.
Ami Fadia’s has documented 504 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 02-May-2024.
Analyst best performing recommendations are on RVMD (REVOLUTION MEDICINES).
The best stock recommendation documented was for RVMD (REVOLUTION MEDICINES) at 10/12/2023. The price target of $34 was fulfilled within 4 days with a profit of $9.8 (40.5%) receiving and performance score of 101.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
5 months 13 days ago
1/3 (33.33%)
$-0.04 (-0.99%)
300
Hold
1
$-0.07 (-6.54%)
5
6 months 8 days ago
4/21 (19.05%)
$0.29 (40.85%)
32
Sell
1
$-0.07 (-6.54%)
3.5
9 months 14 days ago
8/11 (72.73%)
$-0.08 (-7.41%)
55
Hold
1.25
$0.18 (16.82%)
2
9 months 14 days ago
2/5 (40%)
$0.17 (15.74%)
215
Buy
10
1 years 10 months 11 days ago
13/47 (27.66%)
$6.81 (213.48%)
194
Which stock is Ami Fadia is most bullish on?
Which stock is Ami Fadia is most reserved on?
What Year was the first public recommendation made by Ami Fadia?